Medicortex Finland is developing the first, non-invasive, point-of-care diagnostic test for Traumatic Brain Injury.
Medicortex Finland Oyj has raised $2.1M in total funding. The most recent round was Grant. The last funding was announced in October 2022.
Medicortex Finland Oyj's investors include European Innovation Council, U.S. Department of War, Ran Weinstock.
Medicortex Finland Oyj is headquartered in Turku, Finland.
Medicortex Finland is developing the first, non-invasive, point-of-care diagnostic test for Traumatic Brain Injury.
Medicortex Finland Oyj is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Medicortex Finland Oyj — Funding & Investors." VCBacked, October 25, 2022, https://www.vcbacked.co/company/medicortex-finland-oyj. Accessed August 13, 2026.
VCBacked. (2022). Medicortex Finland Oyj — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/medicortex-finland-oyj
{{cite web |title=Medicortex Finland Oyj — Funding & Investors |url=https://www.vcbacked.co/company/medicortex-finland-oyj |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated